Clinical Trial Update: Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast [Phase 4]

View source ↗

Summary

Clinical trial update notes withdrawal of a Phase 4 study evaluating PsASon ultrasound scores in patients with Psoriatic Arthritis treated with apremilast.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Medical University of Graz | Conditions: Psoriatic Arthritis | Phase 4 | Status: WITHDRAWN